Bristol Myers Squibb launches AI content hub in Mumbai
Bristol Myers Squibb (BMS) recently launched Mosaic, an AI-powered content hub in Mumbai, teaming up with Accenture.
Backed by a $130 million investment, Mosaic uses generative AI to quickly spot what healthcare professionals need to know and creates patient-focused content faster than ever.
What is Mosaic?
Mosaic blends BMS's healthcare know-how with Accenture Song's tech skills.
The platform uses AI to help identify what information doctors need and enables rapid creation and sharing of that content—making the process smoother and quicker.
It also marks another milestone in BMS and Accenture's 25-year partnership, with Mumbai playing a key role.
Why does it matter?
Mosaic is built for speed and personalization—two things biopharma really needs right now.
This investment isn't just about one tool; it supports other AI projects too, all aimed at getting useful info to doctors faster and making the patient experience better through timely updates.